Bleichmar Fonti Wants To Retake Lead In Endo Investor Suit
A Chicago-based retirement fund and attorneys from Bleichmar Fonti & Auld asked a federal judge to reinstate them as leads in a stockholder class action against Endo Pharmaceuticals, arguing that the...To view the full article, register now.
Already a subscriber? Click here to view full article